Integrated Personalized Medicine (IPERMED)
IPERMED brings together an international consortium of genetic experts, clinicians and social scientists interested in developing equitable ways to make best use of current medicines and effective methods for translating new genetic knowledge into targeted effective and safer ways to bring medicines into clinical practice. A key aim of IPERMED is to work with patients and the public to improve public understanding of new approaches to improving effectiveness and safety in use of medicines through a personalised approach to their use.
There are complementary interests in pharmacogenomics at Warwick within the Medical School and in affiliated biomedical research groups within Biological Sciences and in Horticultural Research. There are also interests in the Health Economics of pharmacogenetics within Warwick Business School, and in Public Understanding, Ethics and related issues within Social Sciences and in Public Health.
A frequently asked questions area is being developed for public use.
See FAQ For further information about pharmacogenetics and personalised medicines email IPERMED
Seminar Series on Personalising Medicine
4pm Monday 22nd March 2010
Seminar at Warwick Medical School Gibbet Hill Campus Room 0.041
HTA Pharmaceutical Panel Chair: Prof Imti Choonera
Professor in Child Health, University of Nottingham
‘A BETTER WORLD IS POSSIBLE:
How can you help set the research agenda in the UK?’
International RNA Therapeutics Symposium - December 2008
The RNA Therapeutics Symposium is being held within the programme of the 2008
British Pharmacology Society Annual Winter Conference at the Hilton Metropole, Brighton.
Symposium Organizers:
Prof Donald RJ Singer, University of Warwick and Assistant Professor Junlong Zhang, University of Warwick
See Programme.
Downloadable flyer for the Programme.
International Symposium - Progress on Personalizing Medicines: September 2008
Key themes: new markers of genetic variability in drug effects and adverse effects; new rapid approaches to safer drug discovery; reducing adverse drug reactions by pharmacogenomic testing; targeted stem cell therapy; RNA therapeutics; view from the policy makers; ethical issues; explaining risk; regulatory perspectives; importance of supporting eHealth systems.
Supported by a Warwick Institute of Advanced Studies Award and by the Fellowship of Postgraduate Medicine.
International Symposium - From Genes to Patients: New Perspectives on Personalised Medicines: 5th July, 2006
Supported by a 
Award.
Symposium outline A major opportunity to improve treatment of patients arises from the fact that treatment response can be influenced by individual differences in tissue regulation and drug effectiveness. Differences in treatment response may for example arise from genetic and resulting proteomic differences in drug transporters, receptors and in pathways for drug action. Occurrence of adverse drug reactions (ADRs) can also be associated with genetic differences linked to poor drug metabolism. Pharmacogenetic and pharmacoproteomic profiling thus carries the potential to improve earlier selection of effective drug treatments, to reduce incidence of ADRs and to reduce pressures on medical services. The aim of the symposium was to consider ways in which recent developments in genomics and in proteomics can applied to effective personalised medicine profiling in clinical practice and to consider issues important in implementing into practice the necessary health technology innovations. This symposium on Personalised Medicines was held within the 3rd Biennial International AC21 Research Festival hosted by the University of Warwick.
The AC21 Research Festival also included an international symposium on: Health Wealth and Nutrition
Ipermed International Workshop: 12th May 2005
To post information on relevant Seminars and Lectures, please email IPERMED
Useful links
UK Committee on Human Medicines CHM
European Agency for Evaluation of Medicinal Products EMEA
USA Food and Drugs Agency FDA
Australian Therapeutic Goods Administration
TGA
New Zealand Medsafe
New Zealand Centre for Adverse Reactions Monitoring CARM
WHO Collaborating Centre for International Drug Monitoring
Debate: The future of medicine
This website is hosted by the Clinical Pharmacology Section, Clinical Sciences Research Institute, Warwick Medical School, University of Warwick, CV2 2DX, UK: Email link
Progress on Personalizing Medicines - 2008
Fellowship of Postgraduate Medicine
Institute of Advanced Study Incubation Award
Newsletters
SME Membership & Panel
IT Project Management
WHO Collaborating Centre for
International Drug Monitoring
